Dr. Reddy's Laboratories
236 hedge funds and large institutions have $1.5B invested in Dr. Reddy's Laboratories in 2025 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 82 increasing their positions, 75 reducing their positions, and 25 closing their positions.
1,171% more call options, than puts
Call options by funds: $89K | Put options by funds: $7K
64% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 25
4% more funds holding
Funds holding: 228 → 236 (+8)
9% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 75
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less capital invested
Capital invested by funds: $1.5B → $1.5B (-$288K)
0.06% less ownership
Funds ownership: 12.82% → 12.76% (-0.06%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$36.5M |
| 2 |
AIM
Aikya Investment Management
London,
United Kingdom
|
+$8.75M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$6.84M |
| 4 |
Lazard Asset Management
New York
|
+$5.59M |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$5.25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fisher Asset Management
Camas,
Washington
|
-$16.5M |
| 2 |
BlackRock
New York
|
-$12.1M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$8.6M |
| 4 |
Jane Street
New York
|
-$8.57M |
| 5 |
JP Morgan Chase
New York
|
-$7.86M |
RDY Hedge Fund Activity: Q4 2025 in Review
236 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q4 2025, worth a combined $1.5B — down 0.02% from $1.5B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new RDY positions and 25 closed out — a net gain of 16 holders — while 82 added to existing stakes and 75 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $36.5M. The largest seller was Fisher Asset Management, cutting an estimated $16.5M.
- 236 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q4 2025, up from 228 in Q3 2025.
- Funds reported $1.5B of Dr. Reddy's Laboratories stock for Q4 2025, down 0.02% quarter-over-quarter.
- 41 funds opened new Dr. Reddy's Laboratories positions in Q4 2025 and 25 closed out, a net change of +16 holders.
- The largest Dr. Reddy's Laboratories buyer in Q4 2025 was Morgan Stanley, an estimated $36.5M added.
- The largest Dr. Reddy's Laboratories seller in Q4 2025 was Fisher Asset Management, an estimated $16.5M sold.
Based on aggregated 13F filings for Q4 2025.